However, further research is required to determine the most appropriate choice for further development due to discrepancies in results from different laboratories. Incorporation of microfluidics with biosensing devices is also vital for constructing channelized integrated analytical arrangements. In conclusion, FET biosensors have a promising future in the detection of AD biomarkers, but there is still a long way to go in improving their efficacy in clinical practices.